Welcome to our dedicated page for Nuveen S&P 500 Buy-Write Income SEC filings (Ticker: BXMX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nuveen S&P 500 Buy-Write Income Fund (BXMX) SEC filings page on Stock Titan is designed to help investors review the regulatory history of this U.S. closed-end management investment company. BXMX seeks attractive total returns with less volatility by investing in an equity portfolio that aims to substantially replicate the price movements of the S&P 500 Index and by writing index call options, and its filings with the U.S. Securities and Exchange Commission provide formal disclosure around this strategy.
Although no specific filings are listed in the available data here, closed-end funds such as BXMX typically report their activities and financial condition through periodic and transactional filings. These can include annual and semi-annual reports, registration statements, and proxy materials that describe investment objectives, risks, charges, expenses, and any proposed changes to the fund’s structure.
In the case of BXMX, a public communication notes that, in connection with a proposed merger under which BXMX and Nuveen Dow 30℠ Dynamic Overwrite Fund (DIAX) would be combined into Nuveen S&P 500 Dynamic Overwrite Fund (SPXX), the funds expect to file solicitation materials in the form of a proxy statement and/or a joint proxy statement/prospectus included in a registration statement on Form N-14. Investors are urged in that communication to read such materials and any other relevant documents when they become available because they will contain important information about the merger proposal.
On Stock Titan, BXMX-related SEC filings, when available, are presented with AI-powered summaries that explain the key points of lengthy documents in accessible language. This includes highlighting the main elements of proxy statements, registration statements, and other disclosures so that investors can more easily understand the implications of corporate actions, proposed mergers, and changes to the fund’s operations.
Nuveen S&P 500 BuyWrite Income Fund requested removal of its Common Share of Beneficial Interest from listing and registration on the New York Stock Exchange. The Exchange certified it has complied with applicable rules to strike the class and the issuer certified voluntary withdrawal procedures.
Nuveen S&P 500 Buy-Write Income Fund (BXMX) files its certified annual shareholder report for the period ending December 31, 2025, describing performance, distributions, portfolio holdings and corporate actions.
The report shows BXMX paid a quarterly common share distribution of $0.2725 (fiscal YTD $1.0900) and returned 13.80% at NAV for the 12-month period ended December 31, 2025. The filing notes a pending merger approved by the Board on September 17, 2025 to merge BXMX and DIAX into SPXX, subject to shareholder approval and closing conditions. The report also discloses shelf‑offering activity across Funds, net asset and premium/discount statistics, portfolio composition, and an auditor opinion from PricewaterhouseCoopers LLP.
Nuveen S&P 500 BuyWrite Income Fund filed an initial insider ownership report for Joseph Castro, who serves as EVP, Chief Risk & Compliance. This Form 3 establishes his status as an officer of the fund for ongoing insider reporting purposes, but lists no share transactions.
Nuveen S&P 500 BuyWrite Income Fund officer Robert Tanner Page, who serves as VP and Treasurer, submitted a Form 3 as an initial statement of beneficial ownership. The filing lists no buy, sell, acquisition, or disposition transactions, indicating only his reporting status as an insider of the fund.